Navigation Links
The world of in vitro diagnostics is another Midwest success story

I am in a real quandary this week: I have a number of juicy topics I wanted to review with you, including my recent participation in the annual Israel biotech/medical device conference (BIOMED 2006), recent participation in meetings about Indian and my growing insights into the Indian biotech market, happenings in Japan, and other research that has crossed my transom......

Full article >>> br> In last week's article I mentioned that the medical device market (which I thought included the IVD market) probably broke the $200 billion sales revenue mark last year. In fact, according to a market research firm by the name of Health Research International, sales for 2005 topped $220 billion and included 4 market segments:

1. Cardiovascular disease therapies
2. Diagnostic imagi......

Full article >>> /td> 100% 7. Ortho - Clinical Diagnostics (U.S. - New Jersey) $1,400 $50, 514 3% 8. bioMerieux (France) $1,200 $1,200 100% 9. Sysmex (Japan) $716 $716 100% 10. Bio......

Full article >>> oche Diagnostics), with California having another four companies, and New Jersey with two companies and Massachusetts with one company. These figures don't take into account the high numbers of smaller emerging biotech IVD companies that are growing quickly in the Midwest (Madison, Wisconsin, Chicago, and Minneapolis), California, the Boston area and even the Baltimore-Washington, D.C. corridor. I......

Full article >>> clude urine and saliva (the value of these last two is that they are non-invasive: no needle-stick!).

Steve Burrill of Burrill & Co. believes ardently, and I have heard him say this multiple times, that we are moving into a time of high growth of diagnostics given the need for personalized medicine and disease prevention (versus disease treatment).

In the former case, he states t......

Full article >>> nies, only Abbott, Roche, Bayer, and Johnson & Johnson have understood this equation, and all four have historically been involved in the medical device part of the business as much as drugs.

But the coming convergence of drugs, devices, and diagnostics will hasten the need for Big Pharma to pay attention to this important lesson, and get on the diagnostics bandwagon now!

Full article >>>
'"/> By Michael Rosen 06/19/06

Related biology technology :

1. The Right Brain: A neurological solution to the flattening world
2. Northwestern Mutual, American Family make Computerworlds best IT workplaces
3. MailFoundry claims worlds fastest anti-spam filter
4. Fusion 2007: Innovation drives productivity in post 24x7 world
5. Joining the wiki wacki world
6. The flattening world and its impact on U.S. biotech
7. The world of in-vitro diagnostics is another Midwest success story
8. Midwest retains dominant role in 2005 world medical device market
9. Clinton says world needs biofuels, GM crops, and more answers
10. In competitive biotech world, Wisconsin cant afford to fall behind
11. U.S. risks third-world status in key technology
Post Your Comments:

(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
(Date:6/22/2016)... Research and Markets has announced the addition ... their offering. The global ... billion in 2013. The market is expected to grow at a ... 2020, increasing from $50.6 billion in 2015 to $96.6 billion in ... forecast period (2015 to 2020) are discussed. As well, new products ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):